Evidence map›Paper›PMID 33635887›Full record

ArticlePloS one2021

Perceived barriers to Chagas disease screening among a diverse group of prenatal care providers.

Helen Mahoney West, Carly E Milliren, Olivera Vragovic, Julia R Köhler, Christina Yarrington

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
  4. Article
  5. Screening for Chagas Disease Should Be Included in Entry-to-Care Testing for At-Risk People With Human Immunodeficiency Virus (HIV) Living in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Helen Mahoney WestDivision of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, United States of America.ORCID 0000-0003-0282-9069
Carly E MillirenInstitutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, Massachusetts, United States of America.ORCID 0000-0001-6280-8417
Olivera VragovicBoston University School of Medicine, Boston, Massachusetts, United States of America.
Julia R KöhlerDivision of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, United States of America.
Christina YarringtonBoston University School of Medicine, Boston, Massachusetts, United States of America.ORCID 0000-0001-6380-8400
Boston Children's Hospital · USBoston University · US

Funding

Bridging Neglect: improved access to high-quality heart health information and care for communities at risk of Chagas diseaseG08LM013191 · NLM · BOSTON CHILDREN'S HOSPITAL · PI KOEHLER, JULIA R, LEVIN, LEONARD L · 2019 to 2021
$436k
NLM NIH HHS G08 LM013191
6 · The paper itself

Abstract

backgroundChagas disease is a vector borne infection of poverty endemic to Latin America which affects an estimated 40,000 women of child-bearing age in the United States (US). In the US Chagas disease is concentrated among individuals who have lived in endemic areas. Prenatal diagnosis and treatment are needed to prevent congenital transmission. The objective of this study was to assess perceived barriers to Chagas disease screening among prenatal care providers in Obstetrics/Gynecology and Family Medicine Departments of a tertiary care safety-net hospital caring for a significant at-risk population. METHODOLOGY/PRINCIPAL

findingsAn anonymous survey was distributed to 178 Obstetrics/Gynecology and Family Medicine practitioners. Of the 66 respondents, 39% thought Chagas screening was very important, and 48% somewhat important as a public health initiative. One third judged screening patients during clinic visits as very important. Most respondents (64%) reported being familiar with Chagas disease. However, only 32% knew how to order a test and only 22% reported knowing what to do if a test was positive. CONCLUSIONS/SIGNIFICANCE: These findings will be incorporated into measures to facilitate full implementation of Chagas screening, and can inform initiatives at other centers who wish to address this deeply neglected infection among their patient families. Greater integration of information on Chagas disease screening and treatment in medical and nursing education curricula can contribute to addressing this disease with the focus that its potentially fatal sequelae merit.

Indexed as

AdultChagas DiseaseFemaleHumansLatin AmericaMass ScreeningPovertyPregnancyPrenatal CareSurveys and QuestionnairesUnited States

Identifiers

PMID33635887
PMCPMC7909700
OpenAlexW3132552161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.